Cargando…
The effect of smoking on COVID‐19–linked biomarkers in hospitalized patients with COVID‐19
BACKGROUND: The coronavirus pandemic, an infection (coronavirus disease 2019—COVID‐19), caused by severe acute respiratory disease coronavirus 2 (SARS‐CoV‐2), continues to have a strong influence worldwide. Although smoking is a major known risk factor for respiratory infectious disease, the effects...
Autor principal: | Çetin Kargin, Nisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529127/ https://www.ncbi.nlm.nih.gov/pubmed/34463387 http://dx.doi.org/10.1002/jcla.23983 |
Ejemplares similares
-
COVID-19 and smoking: is nicotine the hidden link?
por: Russo, Patrizia, et al.
Publicado: (2020) -
Evaluation of quality of life and depression levels in individuals with Type 2 diabetes
por: Altınok, Ali, et al.
Publicado: (2016) -
Smoking and risk of COVID-19 hospitalization
por: Puebla Neira, Daniel, et al.
Publicado: (2021) -
Molecular Biomarker Identification Using a Network-Based Bioinformatics Approach That Links COVID-19 With Smoking
por: Rahman, Md Anisur, et al.
Publicado: (2023) -
Smoking history and clinical outcomes in COVID-19 hospitalized patients
por: Rossato, Marco, et al.
Publicado: (2022)